Table 1.
Sample ID | Histotype | Stage | Grade | Diagnosis/relapse |
---|---|---|---|---|
PDOVCA 14 | Endometrioid | 3C | G1 | Diagnosis |
PDOVCA 15 | Serous-papillary | 4 | G3 | Relapse |
PDOVCA 17 | Serous-papillary | 3C | G3 | Diagnosis |
PDOVCA 24 | Serous-papillary | 3A | G3 | Relapse |
PDOVCA 36 | Serous | 4 | G3 | Relapse |
PDOVCA 39 | Serous-papillary | 3B | G2 | Relapse |
PDOVCA 44 | Serous-papillary | 3C | G3 | Diagnosis |
PDOVCA 49 | Serous-papillary | 3A | G1 | Relapse |
PDOVCA 52 | Serous-papillary | 3C | G3 | Diagnosis |
PDOVCA 53 | Endometrioid | 3C | G3 | Relapse |
PDOVCA 54 | Serous-papillary | 4 | G1 | Relapse |
PDOVCA 57 | Serous-papillary | 3C | G3 | Relapse |
PDOVCA 58 | Serous-papillary | 3A | G3 | Relapse |
PDOVCA 62 | Serous-papillary | 3C | G3 | Relapse |
PDOVCA 69 | Serous-papillary | 3C | G3 | Relapse |
PDOVCA 70 | Serous-papillary | 3C | G3 | Relapse |
PDOVCA 82 | Serous-papillary | 3C | G3 | Relapse |
Histotype, stage, and grade refer to the patient samples from whom PDXs were derived. Diagnosis/relapse indicates that PDXs were established from ascitic fluid samples obtained at diagnosis or relapse, respectively.